Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial

Background Hypovitaminosis D is associated with Sarcopenic Obesity (SO), but evidence from randomized Vitamin D 3 (VD3) trials is scarce. Objective Compare the effect of VD3 supplementation, at two doses, on SO indices at 12 months. Methods Overweight older adults (>65 years) with baseline 25-hyd...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Jabbour, Jana (author)
مؤلفون آخرون: Rahme, Maya (author), Mahfoud, Ziyad R. (author), El-Hajj Fuleihan, Ghada (author)
التنسيق: article
منشور في: 2022
الوصول للمادة أونلاين:http://hdl.handle.net/10725/16552
https://doi.org/10.1007/s12020-021-02951-3
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://link.springer.com/article/10.1007/s12020-021-02951-3
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513472914522112
author Jabbour, Jana
author2 Rahme, Maya
Mahfoud, Ziyad R.
El-Hajj Fuleihan, Ghada
author2_role author
author
author
author_facet Jabbour, Jana
Rahme, Maya
Mahfoud, Ziyad R.
El-Hajj Fuleihan, Ghada
author_role author
dc.creator.none.fl_str_mv Jabbour, Jana
Rahme, Maya
Mahfoud, Ziyad R.
El-Hajj Fuleihan, Ghada
dc.date.none.fl_str_mv 2022
2022-04
2025-02-12T14:07:17Z
2025-02-12T14:07:17Z
dc.identifier.none.fl_str_mv 1559-0100
http://hdl.handle.net/10725/16552
https://doi.org/10.1007/s12020-021-02951-3
Jabbour, J., Rahme, M., Mahfoud, Z. R., & El-Hajj Fuleihan, G. (2022). Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial. Endocrine, 76, 162-171.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://link.springer.com/article/10.1007/s12020-021-02951-3
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Endocrine
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Background Hypovitaminosis D is associated with Sarcopenic Obesity (SO), but evidence from randomized Vitamin D 3 (VD3) trials is scarce. Objective Compare the effect of VD3 supplementation, at two doses, on SO indices at 12 months. Methods Overweight older adults (>65 years) with baseline 25-hydroxyvitamin D (25OHD) of 10–30 ng/mL were recruited in this double-blind, randomized, controlled multicenter trial (clinicaltrial.gov identifier: NCT01315366). All subjects received 1000 mg calcium citrate/day and underwent total body Dual-energy X-ray Absorptiometry for body composition assessment. Low Dose Group (LDG) and High Dose Group (HDG) received 600 IU -Institute of Medicine (IOM) Recommended Dietary Allowance (RDA)- and 3750 IU VD3/day, respectively. Results Mean age was 71 ± 4.6 years, 55% females, BMI: 30.2 ± 4.5 Kg/m2, and 43% had metabolic syndrome. There were no differences in baseline characteristics between groups. At 12 months, 248 participants had body composition data, 122 in LDG and 126 in HDG. Proportions of patients with diminished muscle mass, muscle strength, and visceral adiposity did not differ between the 2 groups at baseline or 12 months. Similarly, no significant differences were noted in the proportion of patients with SO at study entry (1.8% in LDG vs 1.6% HDG; p = 0.99) and at 12 months (3.7% in LDG vs. 0.9% HDG; p = 0.18) across arms. Conclusions Weekly VD3, at the daily equivalent of 3750 IU/day, did not improve indices of sarcopenia nor adiposity compared to the IOM RDA dose in adults.
eu_rights_str_mv openAccess
format article
id LAURepo_565ac6990af2ef8d58f76f4fded99db0
identifier_str_mv 1559-0100
Jabbour, J., Rahme, M., Mahfoud, Z. R., & El-Hajj Fuleihan, G. (2022). Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial. Endocrine, 76, 162-171.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/16552
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trialJabbour, JanaRahme, MayaMahfoud, Ziyad R.El-Hajj Fuleihan, GhadaBackground Hypovitaminosis D is associated with Sarcopenic Obesity (SO), but evidence from randomized Vitamin D 3 (VD3) trials is scarce. Objective Compare the effect of VD3 supplementation, at two doses, on SO indices at 12 months. Methods Overweight older adults (>65 years) with baseline 25-hydroxyvitamin D (25OHD) of 10–30 ng/mL were recruited in this double-blind, randomized, controlled multicenter trial (clinicaltrial.gov identifier: NCT01315366). All subjects received 1000 mg calcium citrate/day and underwent total body Dual-energy X-ray Absorptiometry for body composition assessment. Low Dose Group (LDG) and High Dose Group (HDG) received 600 IU -Institute of Medicine (IOM) Recommended Dietary Allowance (RDA)- and 3750 IU VD3/day, respectively. Results Mean age was 71 ± 4.6 years, 55% females, BMI: 30.2 ± 4.5 Kg/m2, and 43% had metabolic syndrome. There were no differences in baseline characteristics between groups. At 12 months, 248 participants had body composition data, 122 in LDG and 126 in HDG. Proportions of patients with diminished muscle mass, muscle strength, and visceral adiposity did not differ between the 2 groups at baseline or 12 months. Similarly, no significant differences were noted in the proportion of patients with SO at study entry (1.8% in LDG vs 1.6% HDG; p = 0.99) and at 12 months (3.7% in LDG vs. 0.9% HDG; p = 0.18) across arms. Conclusions Weekly VD3, at the daily equivalent of 3750 IU/day, did not improve indices of sarcopenia nor adiposity compared to the IOM RDA dose in adults.Published2025-02-12T14:07:17Z2025-02-12T14:07:17Z20222022-04Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1559-0100http://hdl.handle.net/10725/16552https://doi.org/10.1007/s12020-021-02951-3Jabbour, J., Rahme, M., Mahfoud, Z. R., & El-Hajj Fuleihan, G. (2022). Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial. Endocrine, 76, 162-171.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttps://link.springer.com/article/10.1007/s12020-021-02951-3enEndocrineinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/165522025-02-26T14:47:21Z
spellingShingle Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial
Jabbour, Jana
status_str publishedVersion
title Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial
title_full Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial
title_fullStr Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial
title_full_unstemmed Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial
title_short Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial
title_sort Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial
url http://hdl.handle.net/10725/16552
https://doi.org/10.1007/s12020-021-02951-3
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://link.springer.com/article/10.1007/s12020-021-02951-3